TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Jane Chao, Ph.D.
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

Ceribell obtained FDA 510(k) clearance for its ClarityⓇ algorithm, becoming the first AI-powered point-of-care EEG technology capable of detecting electrographic seizures across all patient ages, from pre-term neonates to adults.

Insights
AEM   positive

92% YTD performance, record Q3 earnings, reduced debt, 16 out of 17 analysts recommend buying with 18% upside potential


CBLL   positive

Achieved significant FDA regulatory milestone, expanded technological capabilities, addressed critical unmet medical need in neonatal seizure detection